Treatment of a patient with congenital analbuminemia with atorvastatin and albumin infusion

Table 1 Changes in serum lipid profile during treatment with atorvastatin at increasing dosages

Time	Treatment	TC(mg/dL)	TG(mg/dL)	HDL-C (mg/dL)	LDL-C (mg/dL)	Apo A1(mg/dL)	Apo B(mg/dL)	Lp (a) (mg/dL)	ALT(UI)	AST(UI)	CK(U/L)	Alb(g/L)
Week 20	Diet	409	97	53	336		225		20	26	195	1.1
Week 0	Diet	397	85	52	328	124	203	90.5	18	18	162	0.8
Week 1	At 10 mg	384	144	45	310				25	30	193	0.8
Week 2	At 10 mg	307	104	52	234				18	20	181	0.8
Week 3	At 10 mg	284	122	45	214				21	22	138	0.7
Week 4	At 10 mg	261	111	44	194	162	151	85.3	21	15	147	0.7
Week 5	At 20 mg	303	100	60	223				14	20	160	0.8
Week 6	At 20 mg	290	99	61	209				20	20	147	0.7
Week 8	At 20 mg	240	130	49	165			80.0	19	21	123	0.8
Week 10	At 20 mg	263	93	45	199				22	15	123	0.8
Week 12	At 20 mg	264	84	36	211				25	20	192	0.7
Week 14	At 20 mg	264	88	47	199				23	17	172	0.8
Week 16	At 20 mg	250	83	49	184			76.6	22	17	142	0.7
Week 18	At 20 mg	279	119	42	213				17	17	131	0.7
Week 20	At 20 mg	272	90	57	197	224	160		23	24	195	1.0
Week 21	At 40 mg	243	90	59	166	199	165	72.6	25	30	189	0.7
Week 26	Diet	375	113	52	300			89.6	19	15	153
Week 28	Diet	435	124	51	359	224	206		22	10	137	0.6

TC: Total cholesterol; TG: Triglycerides; HDL-C: High density lipoprotein-cholesterol; LDL: Low density lipoprotein-cholesterol; Apo: Apolipoprotein; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CK: Creatine phosphokinase; Alb: Albumin.